Organoid generation from mouse mammary tumors captures the genetic heterogeneity of clinically relevant copy number alterations

Breast cancer metastases exhibit many different genetic alterations, including copy number amplifications. Using publicly available datasets, we identify copy number amplifications in metastatic breast tumor samples and using our organoid-based metastasis assays, and we validate FGFR1 is amplified i...

Full description

Saved in:
Bibliographic Details
Published inbioRxiv : the preprint server for biology
Main Authors Lake, Katherine E, Colonetta, Megan M, Smith, Clayton A, Martinez-Algarin, Kenneth, Saunders, Kaitlyn, Mohta, Sakshi, Pena, Jacob, McArthur, Heather L, Reddy, Sangeetha M, Roussos-Torres, Evanthia T, Chen, Elizabeth H, Chan, Isaac S
Format Journal Article
LanguageEnglish
Published United States 31.01.2023
Online AccessGet more information

Cover

More Information
Summary:Breast cancer metastases exhibit many different genetic alterations, including copy number amplifications. Using publicly available datasets, we identify copy number amplifications in metastatic breast tumor samples and using our organoid-based metastasis assays, and we validate FGFR1 is amplified in collectively migrating organoids. Because the heterogeneity of breast tumors is increasingly becoming relevant to clinical practice, we demonstrate our organoid method captures genetic heterogeneity of individual tumors.